Literature DB >> 11704857

Maturation sensitive and resistant t(15;17) NB4 cell lines as tools for APL physiopathology: nomenclature of cells and repertory of their known genetic alterations and phenotypes.

M J Roussel1, M Lanotte.   

Abstract

Chromosomal translocations, leading to gene rearrangements that generate chimerical proteins, represent one of the initiating events of leukemia. Preleukemia cells eventually develop into overt leukemia by occurrence of secondary genetic alterations (tumor progression). The physiopathology of leukemia has made considerable progress during the last two decades, due to molecular biology investigations on the role played by the altered genes, during neoplasic hemopoiesis. In vitro studies have been facilitated by the establishment of stable leukemia cell lines bearing these gene rearrangements and secondary gene mutations. Investigations on acute promyelocytic leukemia (APL) have benefited from maturation sensitive and resistant cell lines (NB4 and UF-1) derived from APL patient's leukemia cells and bearing the t(15;17). The information concerning the NB4 cell line (responsiveness to retinoid/rexinoid, cAMP, arsenic, mutations causing resistance) is spread in an abundant literature. In this paper, we briefly recapitulate the cellular and molecular features of this cell line and its subclones with the aim of facilitating investigators in their choice of the most appropriate tool for their studies. As redundancy of several names given to NB4 sublines has sometimes created difficulties, we propose a nomenclature for the various NB4 sublines that most investigators certainly would be agreed with.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704857     DOI: 10.1038/sj.onc.1204863

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its oncogenic counterpart PML-RARA.

Authors:  Andrea Rabellino; Brandon Carter; Georgia Konstantinidou; Shwu-Yuan Wu; Alessandro Rimessi; Lauren A Byers; John V Heymach; Luc Girard; Cheng-Ming Chiang; Julie Teruya-Feldstein; Pier Paolo Scaglioni
Journal:  Cancer Res       Date:  2012-03-09       Impact factor: 12.701

2.  Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation.

Authors:  Guoliang Li; Xiaoan Ruan; Raymond K Auerbach; Kuljeet Singh Sandhu; Meizhen Zheng; Ping Wang; Huay Mei Poh; Yufen Goh; Joanne Lim; Jingyao Zhang; Hui Shan Sim; Su Qin Peh; Fabianus Hendriyan Mulawadi; Chin Thing Ong; Yuriy L Orlov; Shuzhen Hong; Zhizhuo Zhang; Steve Landt; Debasish Raha; Ghia Euskirchen; Chia-Lin Wei; Weihong Ge; Huaien Wang; Carrie Davis; Katherine I Fisher-Aylor; Ali Mortazavi; Mark Gerstein; Thomas Gingeras; Barbara Wold; Yi Sun; Melissa J Fullwood; Edwin Cheung; Edison Liu; Wing-Kin Sung; Michael Snyder; Yijun Ruan
Journal:  Cell       Date:  2012-01-20       Impact factor: 41.582

3.  LG-362B targets PML-RARα and blocks ATRA resistance of acute promyelocytic leukemia.

Authors:  X Wang; Q Lin; F Lv; N Liu; Y Xu; M Liu; Y Chen; Z Yi
Journal:  Leukemia       Date:  2016-03-08       Impact factor: 11.528

4.  Leukemic cell xenograft in zebrafish embryo for investigating drug efficacy.

Authors:  Benoist Pruvot; Arnaud Jacquel; Nathalie Droin; Patrick Auberger; Didier Bouscary; Jérome Tamburini; Marc Muller; Michaela Fontenay; Johanna Chluba; Eric Solary
Journal:  Haematologica       Date:  2011-01-12       Impact factor: 9.941

5.  miR-125b, a target of CDX2, regulates cell differentiation through repression of the core binding factor in hematopoietic malignancies.

Authors:  Kang-Yu Lin; Xing-Ju Zhang; Dan-Dan Feng; Hua Zhang; Cheng-Wu Zeng; Bo-Wei Han; Ai-Dong Zhou; Liang-Hu Qu; Ling Xu; Yue-Qin Chen
Journal:  J Biol Chem       Date:  2011-09-08       Impact factor: 5.157

6.  Targeting expression of the leukemogenic PML-RARα fusion protein by lentiviral vector-mediated small interfering RNA results in leukemic cell differentiation and apoptosis.

Authors:  Simone V Ward; Thomas Sternsdorf; Niels-Bjarne Woods
Journal:  Hum Gene Ther       Date:  2011-11-11       Impact factor: 5.695

Review 7.  Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Authors:  Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 8.  Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and Cancer.

Authors:  Faith Stevison; Jing Jing; Sasmita Tripathy; Nina Isoherranen
Journal:  Adv Pharmacol       Date:  2015-05-27

9.  RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells.

Authors:  Hidenori Hattori; Xueqing Zhang; Yonghui Jia; Kulandayan K Subramanian; Hakryul Jo; Fabien Loison; Peter E Newburger; Hongbo R Luo
Journal:  Blood       Date:  2007-04-09       Impact factor: 22.113

10.  The histone demethylase PHF8 governs retinoic acid response in acute promyelocytic leukemia.

Authors:  Maria Francisca Arteaga; Jan-Henrik Mikesch; Jihui Qiu; Jesper Christensen; Kristian Helin; Scott C Kogan; Shuo Dong; Chi Wai Eric So
Journal:  Cancer Cell       Date:  2013-03-18       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.